Clinical trial
Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria - WP5
NCT01311154 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria - WP5
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 28, 2011
- Completion date
- July 31, 2015
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focus of study: carriers of resistant enterobacteriaceae.